PBT-1033

DB05565ExperimentalSmall molecule

Investigated for use/treatment in alzheimer's disease.

Chemical structure of PBT-1033
Primary indication
Investigated for use/treatment in alzheimer's disease.Curator reviewed
Formula / weight
C12H12Cl2N2O · 271.14 g/mol (avg)
Also known as
5,7-dichloro-2-(dimethylaminomethyl)quinolin-8-ol · 8-quinolinol, 5,7-dichloro-2-((dimethylamino)methyl)-
Code names
PB 1033 · PBT-2

Resolves to

Compound
UNIIQ7K6GJQ4O4CAS747408-78-2ChEMBLCHEMBL3634131
Structure
InChIKeyYZPOQCQXOSEMAZ-UHFFFAOYSA-NSMILESCN(C)CC1=CC=C2C(Cl)=CC(Cl)=C(O)C2=N1
Targets
P10636MAPT

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with PBT-1033, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In